Corrigendum to "Safety and efficacy of semaglutide in post kidney transplants patients with type 2 diabetes or post-transplant diabetes" [J. Clin. Translat. Endoc. 36C (2024) 100343].
Journal of clinical & translational endocrinology2024PMID: 39764278
[This corrects the article DOI: 10.1016/j.jcte.2024.100343.].
Authors
Mohammed Mahzari, Moeber; Buraykan Alluhayyan, Omar; Hamad Almutairi, Mahdi; Abdullah Bayounis, Mohammed; Hasan Alrayani, Yazeed; Omair, Amir A; Saad Alshahrani, Awad
Corrigendum to "Safety and efficacy of semaglutide in post kidney transplants patients with type 2 diabetes or post-transplant diabetes" [J. Clin. Translat. Endoc. 36C (2024) 100343]. | Pepdox